Bioethicist Carl Elliott has a terrific and disturbing article in The New Yorker (subscription required for full text) about the demand for healthy human subjects for drug safety trials. Elliott quotes an attorney representing volunteers injured at commercial testing sites: "This is something the poor do so that the rich can get better drugs."